Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma - Quiz - MDSpire

Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma

  • By

  • Hao Su

  • Xinyu Zhao

  • Xiaoyu Qin

  • Xu Zhou

  • Mianli Li

  • Lijun Tian

  • June 19, 2026

  • 0 min

Share

Original Source(s)

Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma

  • by Hao Su, Xinyu Zhao, Xiaoyu Qin, Xu Zhou, Mianli Li, Lijun Tian

  • June 19, 2026

Related Content

Homologous recombination pathway alterations in basal-like breast cancer

Trastuzumab emtansine versus trastuzumab plus pertuzumab for HER2-positive breast cancer with residual disease after neoadjuvant therapy: a real-world study

Radiomics and deep learning in upper tract urothelial carcinoma: advancing preoperative risk stratification and clinical decision-making